Opioids Initiative

Combating the Opioid Epidemic in America

The National Alliance brings together coalition members and healthcare stakeholders to address the issues and challenges employers face regarding the opioid epidemic. This initiative demonstrates the impact of opioid use on employers and employees and includes effective interventions — including healthcare and community partnerships — to prevent and treat opioid misuse. A number of coalitions have made focused efforts in their markets.

Our Path Forward

A panel of coalition leaders is defining a national framework and conducting a baseline assessment of employer efforts to deploy best practices nationwide. Alternative payment models, and an Action Brief and other educational tools will provide employers with strategies and best practices to combat opioid misuse within the workplace.

Opioids Resources for Employers

Opioids in the Workplace

Opioids Support

Helping employers support prevention, treatment and recovery

Accelerating Opioid Safety

Accelerating Safety

A guide for provider organizations to improve opioid safety

Pain Management

Pain Management

Strategies to protect employees from opioid misuse

Our Collective Value Agenda:

Uniting and raising our voices together

  • Help employers understand the overall cost to their populations
  • Deploy an action plan for combating opioid misuse in the workplace
  • Advance the development of alternative payment/bundle management
  • Build relationships with health plans, employers, PBMs and other stakeholders to strengthen opioid prevention efforts
  • Use opioid management findings from the PBM Assessment and eValue8™ Mental Health Deep Dive to inform future efforts to deter opioid use and misuse
  • Adopt a national framework for coalition members to support in local and regional markets

“One of the biggest remaining gaps in confronting the opioid crisis in the workplace is employee education. Employers have been reluctant to accept that they or their employees may be affected. The misinformation and misunderstanding around opioids are significant and require a concerted educational effort.”

Gaye Fortner, CEO, HealthCare 21 and Opioid Initiative Advisor